• News

    • Latest news
    • Press releases
    • Upcoming events

Go back

Sakura Finetek Announces the Move of Its Genemed Operations to Torrance, California.

Community outreach    February 06, 2018    America, Global

TORRANCE, CA – Sakura Finetek USA, Inc. today announced the relocation of its Genemed advanced staining reagents development and manufacturing operations from South San Francisco to its expanded campus in Torrance, California.
 
Strategically acquired from Genemed Biotechnologies in December 2015, the Genemed operation specializes in development of tissue-based Advanced Staining reagents and consumables used for cancer detection, diagnosis and monitoring.  Products manufactured by Genemed include antibodies, probes, detection systems and ancillary reagents for immunohistochemistry and in-situ hybridization, which are optimized for Sakura Finetek’s Genie Advanced Staining System as well as being sold for manual use.
 
“We are pleased to move and welcome our highly skilled and expert Genemed staff to our newly expanded facility in Torrance”, said Takashi Tsuzuki, Chairman and Chief Executive Officer, Sakura Finetek USA.  “Combining operations will create greater efficiencies for our Advanced Staining business and allow the Genemed Team to fully leverage Sakura’s history of innovation and market-leading quality systems.”
 
In preparation for the move, Sakura added a third building and expanded its ISO 13485 certified facility to add 45,000 square feet of space that includes research and development laboratories, reagent manufacturing operations, offices for the relocated team and a new state of the art general warehouse.
 
“Genemed and its employees are excited about the relocation and the opportunity to operate under the same roof with the rest of Sakura Finetek USA, Inc’s research and development and manufacturing teams” said Peter Luu, Senior Vice President of the Genemed operations. “Combining operations in our beautiful new facility will increase productivity and enhance development of reagents to better support our highly differentiated Genie Advanced Staining system for our clinical and life science research customers”.
 

Genie Fully Automated IHC and ISH Staining

The Tissue-Tek Genie® Advanced Staining System is Sakura Finetek’s new platform for immunohistochemistry (IHC) and in-situ hybridization (ISH).  It underscores the company’s commitment to develop a full and complete line of innovative automated solutions for clinical and life science research laboratories. The Genie product line was developed to provide uncompromised quality of IHC and ISH staining with predictable turnaround time (TAT), combined with the well-established and trusted instrument reliability respected for many decades.
 
With Genie, laboratories not only gain the ability to stain individual slides and entire cases simultaneously, but can add any slide for IHC or ISH without affecting the TAT of any slides already being stained.
 
Sakura Finetek offers two prediluted, ready-to-use antibody formats for the Genie system for fast and accurate staining to enable pathologists to diagnose accurately and faster.
 
The entire system enables a LEAN workflow management for laboratories to easily and quickly adapt to changes in demand, test menus or TAT.  The 30 fully independent staining stations eliminate the need to group slides by antibody or lose valuable slide positions on trays when not being able to find enough slide for an efficient run, an especially challenging situation during peak demand when pathologists are waiting to diagnose patients’ cancer cases. The scheduler-free process inside the instrument ensures that every protocol is stained to its one shortest optimized time, independent of how many slides are added; this is innovation in instrumentation, the first and only of its kind, that makes the first laboratories much faster and provide them with a new higher reproducibility in pristine stain quality.
 

About Sakura Finetek, USA, Inc.

With the U.S. office based in Torrance, California, Sakura Finetek is the global leader in continuous innovation for pathology by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality and customer care. With a strategic focus on end-to-end automation, Sakura Finetek continues to lead the industry in the development and commercialization of automated histology instrumentation and consumables for anatomic pathology.  Sakura Finetek systems dramatically increase efficiency, standardize results, and allow customers to more simply manage their daily workload while significantly influencing patient care.
 
For more information regarding the Tissue-Tek Genie Advanced Staining Solutions or any Sakura Finetek products, please visit our website or contact:
 
Erico von Bueren
Director of Marketing
Sakura Finetek USA, Inc.
1750 W. 214th St.
Torrance, CA 90501
evonbueren@sakuraus.com
 
 

TORRANCE, CA – Sakura Finetek USA, Inc. today announced the relocation of its Genemed advanced staining reagents development and manufacturing operations from South San Francisco to its expanded campus in Torrance, California.    

Strategically acquired from Genemed Biotechnologies in December 2015, the Genemed operation specializes in development of tissue-based Advanced Staining reagents and consumables used for cancer detection, diagnosis and monitoring.  Products manufactured by Genemed include antibodies, probes, detection systems and ancillary reagents for immunohistochemistry and in-situ hybridization, which are optimized for Sakura Finetek’s Genie Advanced Staining System as well as being sold for manual use.   

Download PDF

Print